Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Adalimumab
Humira
Not routinely available
SMC (1173/16)
11/07/2016
Indication
Treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy. (This licence extension relates to previous SMC advice (468/08).
Therapeutic Area
Skin
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
Pre-filled Pen, Pre-filled Syringe and Vial
Comments
None
Link to Advice
Advice Published
11/07/2016
SMC Submission Type
Non submission
SMC Status
Not recommended